RLFTY — MindMaze Therapeutics Holding SA

OTC · Health Care · Pharmaceuticals · CIK 1854078 · Switzerland
Last close
$0.42
Market Cap
$66.59M
52W High
$1.73
52W Low
$0.42
ADV30
0
Next earnings
MindMaze Therapeutics Holding SA operates as a commercial-stage biopharmaceutical and neurotechnology company in Asia, the United States, Switzerland, rest of Europe, and internationally. The company offers MindPod system, a supervised in-clinic neurorehabilitation system designed to initiate and intensify the recovery journey; MindMotion GO, which extends protocolized neurotherapeutics into outpatient and home settings; MindMotion Companion, an application that manages prescription, monitoring and documentation across MindMaze Therapeutics' neurotherapeutics ecosystem; and the patient app, a patient-facing mobile application, that supports clinic-to-home continuity by making prescribed therapy easy to follow outside the clinic. It also provides Izar hand therapy device which supports fine motor rehabilitation; Physilog sensor, a wearable inertial sensing device designed to quantify human movement; toaprun, a training for Parkinson's therapy-reimagined through play. The company was founded in 2012 and is headquartered in Geneva, Switzerland.
No quarterly fundamentals indexed for this ticker.

Yahoo Snapshot (yfinance, live)

Total Revenue
$642,000
EBITDA
$-9,143,000
Free Cash Flow
Enterprise Value
Total Cash
Total Debt
Shares Out
157,602,044
Trailing EPS
$-0.60
Book Value
$0.31
ROE
-51.6%
ROA
-25.5%
Div Yield

Annual Trend (SEC EDGAR, last 2y)

Revenues vs Net Income (last 2y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 642,000 -10,515,000 -9,906,000 51,530,000 13,189,000 -7,208,000
Dec 2024 0 -2,000 -1,000 93,000 7,000 -3,000

Peers — same industry

TickerNameMarket CapLastDaily %
SER Serina Therapeutics, Inc. $66.80M $2.63
APLM Apollomics Inc. $66.92M $23.11
BOLD Boundless Bio, Inc. $67.33M $2.96
INCR Intercure Ltd. $64.91M $5.48
HYFT MindWalk Holdings Corp. $64.84M $1.38

News headlines (Yahoo Finance, 1h cache)

MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics
2025-12-23 06:20 · Yahoo
Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics
2025-12-15 06:20 · Yahoo
Relief Therapeutics Shareholders Approve Business Combination with NeuroX
2025-11-14 17:40 · Yahoo
Relief Therapeutics Announces Positive Results from Pivotal Bioequivalence Study of RLF-OD032
2025-10-29 06:20 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.